Clinical Approach to Medical Management of Type 2 Diabetes
Clinical Approach to Medical Management of Type 2 Diabetes
Clinical Approach to Medical Management of Type 2 Diabetes
SHOW LESS
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Rosiglitazone<br />
• Rosiglitazone is associated<br />
with an increased risk <strong>of</strong> CV<br />
events, removed from the<br />
market in Europe, use<br />
restricted by the FDA<br />
– Must prove other medications<br />
are not effective or<br />
Rosiglitazone is the only<br />
alternative<br />
Nissen et al, Arch Intern Med, 2010
Change language